Back
Madrigal Pharmaceuticals Stock Predictions
Sponsored
MDGL
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
MDGL
Madrigal Pharmaceuticals
Last Price:
233.88
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Madrigal Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 69.2% based on the past 17 years of stock performance.
- Madrigal Pharmaceuticals has risen higher in 9 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%
-
Is Madrigal Pharmaceuticals Stock Undervalued?
The current Madrigal Pharmaceuticals [MDGL] share price is $233.44. The Score for MDGL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 69.2% based on the past 17 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Sell
48
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals overpriced?
- Madrigal Pharmaceuticals has risen higher in 9 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.94%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
299.98
52-Week Low:
119.76
Prediction Charts
Market Cap:
5.07B
Price in USD:
233.44
Volume:
290.58K
Beta:
1.04
Technical Analysis
SMA50:
256.25
SMA100:
252.60
SMA200:
242.81
52-Wk Change:
44.62%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?
Yes, Madrigal Pharmaceuticals is a publicly traded company. -
What is the Madrigal Pharmaceuticals stock quote today?
The Madrigal Pharmaceuticals stock price is 233.44 USD today. -
How to buy Madrigal Pharmaceuticals stock online?
You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-3 | 246.32 | 236.57 | 250.00 | 232.77 |
Sep-4 | 236.40 | 245.34 | 245.59 | 233.23 |
Sep-5 | 246.24 | 246.11 | 248.55 | 241.97 |
Sep-6 | 249.62 | 243.89 | 249.62 | 241.64 |
Sep-9 | 244.78 | 238.84 | 247.60 | 233.81 |
Sep-10 | 239.03 | 235.69 | 239.03 | 232.00 |
Sep-11 | 235.36 | 232.87 | 236.11 | 230.56 |
Sep-12 | 230.20 | 234.76 | 238.41 | 230.02 |
Sep-13 | 235.32 | 241.80 | 245.75 | 235.32 |
Sep-16 | 241.56 | 233.39 | 241.63 | 232.41 |
Sep-17 | 235.35 | 233.36 | 240.04 | 232.40 |
Sep-18 | 233.76 | 233.33 | 239.53 | 230.72 |
Sep-19 | 238.11 | 242.25 | 248.19 | 233.50 |
Sep-20 | 243.47 | 233.44 | 244.23 | 233.00 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.